Abstract
Body dysmorphic disorder (BDD) is an obsessive–compulsive disorder-related psychiatric condition characterized by an intense preoccupation with perceived physical flaws that are not observable by others. BDD affects ~2% of the adult population but is underdiagnosed, partly owing to limited clinician awareness, and undertreated, partly due to limited access to treatment. Research on the aetiology of BDD is scarce but likely involves an interplay between genetic and environmental factors. A few studies suggest functional and structural brain differences (compared with controls) in the regions involved in visual and emotional processing, although firm conclusions about the pathophysiology of the disorder cannot be made at this stage. Diagnosis requires the presence of repetitive behaviours or mental acts typically aimed at checking, correcting or concealing perceived flaws. The disorder typically has its onset before 18 years of age, with a female preponderance in youth but no major gender disparity in adults. Quality of life is markedly impaired across multiple domains and suicide risk is considerable. Evidence-based treatments include cognitive behavioural therapy and selective serotonin reuptake inhibitors. Future research should focus on understanding the biological and environmental factors that increase the risk of BDD, and on improving access to effective treatments, thereby addressing a critical gap in care for this often misunderstood and overlooked disorder.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 1 digital issues and online access to articles
$119.00 per year
only $119.00 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Jassi, A. & Krebs, G. Body dysmorphic disorder. Psychiatr. Clin. North Am. 46, 197–209 (2023).
Buhlmann, U. & Winter, A. Perceived ugliness: an update on treatment-relevant aspects of body dysmorphic disorder. Curr. Psychiatry Rep. 13, 283–288 (2011).
Rautio, D. et al. Intentional self-harm and death by suicide in body dysmorphic disorder: a nationwide cohort study. Biol. Psychiatry 96, 868–875 (2024). This is the first study reporting risks of intentional self-harm and deaths by suicide at the population level using a cohort of over 2,800 individuals with BDD.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 3rd edn (American Psychiatric Publishing, 1987).
World Health Organization. International Classification of Diseases 11th revision (WHO, 2022).
Phillips, K. A. et al. Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety 27, 573–591 (2010).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Publishing, 2013).
Phillips, K. A., Menard, W., Quinn, E., Didie, E. R. & Stout, R. L. A 4-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder. Psychol. Med. 43, 1109–1117 (2013).
Enander, J. et al. Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial. BMJ 352, i241 (2016). This large RCT evaluated the efficacy of therapist-guided, internet-based CBT for BDD and has shown significant improvements in symptom severity, despite no face-to-face contact with a therapist, and gains were maintained for at least 3 months after the end of treatment.
Marques, L. et al. Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms. Depress Anxiety 27, 470–475 (2010).
Veale, D., Gledhill, L. J., Christodoulou, P. & Hodsoll, J. Body dysmorphic disorder in different settings: a systematic review and estimated weighted prevalence. Body Image 18, 168–186 (2016). This systematic review provides the most updated estimates of BDD prevalence across different settings and populations.
Bjornsson, A. S. et al. Age at onset and clinical correlates in body dysmorphic disorder. Compr. Psychiatry 54, 893–903 (2013).
Krebs, G., Clark, B., Ford, T. & Stringaris, A. Epidemiology of body dysmorphic disorder and appearance preoccupation in youth: prevalence, comorbidity and psychosocial impairment. J. Am. Acad. Child Adolesc. Psychiatry 64, 203–211 (2024).
Buhlmann, U. et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res. 178, 171–175 (2010).
Schieber, K., Kollei, I., De Zwaan, M. & Martin, A. Classification of body dysmorphic disorder — what is the advantage of the new DSM-5 criteria? J. Psychosom. Res. 78, 223–227 (2015).
Veale, D. et al. Body dysmorphic disorder: a survey of fifty cases. Br. J. Psychiatry 169, 196–201 (1996).
Phillips, K. A. et al. Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res. 141, 305–314 (2006).
Rautio, D. et al. Clinical characteristics of 172 children and adolescents with body dysmorphic disorder. Eur. Child Adolesc. Psychiatry 31, 133–144 (2022).
Enander, J. et al. Prevalence and heritability of body dysmorphic symptoms in adolescents and young adults: a population-based nationwide twin study. Psychol. Med. 48, 2740–2747 (2018).
Phillips, K. A. & Diaz, S. F. Gender differences in body dysmorphic disorder. J. Nerv. Ment. Dis. 185, 570–577 (1997).
Pellegrini, L. et al. Suicidality in patients with obsessive-compulsive and related disorders (OCRDs): a meta-analysis. Compr. Psychiatry 108, 152246 (2021).
Phillips, K. A. & Menard, W. Suicidality in body dysmorphic disorder: a prospective study. Am. J. Psychiatry 163, 1280–1282 (2006).
Cotterill, J. A. & Cunliffe, W. J. Suicide in dermatological patients. Br. J. Dermatol. 137, 246–250 (1997).
Phillips, K. A. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder (Oxford University Press, 2005).
Fernández De La Cruz, L. et al. All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study. BMJ 384, e077564 (2024).
Mataix-Cols, D. et al. All-cause and cause-specific mortality among individuals with hypochondriasis. JAMA Psychiatry 81, 284–291 (2023).
Fernández De La Cruz, L. et al. Suicide in Tourette’s and chronic tic disorders. Biol. Psychiatry 82, 111–118 (2017).
Phillips, K. A., Menard, W., Fay, C. & Weisberg, R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 46, 317–325 (2005).
Bienvenu, O. J. et al. The relationship of obsessive–compulsive disorder to possible spectrum disorders: results from a family study. Biol. Psychiatry 48, 287–293 (2000).
Longobardi, C., Badenes-Ribera, L. & Fabris, M. A. Adverse childhood experiences and body dysmorphic symptoms: a meta-analysis. Body Image 40, 267–284 (2022).
Knafo, A. & Jaffee, S. R. Gene–environment correlation in developmental psychopathology. Dev. Psychopathol. 25, 1–6 (2013).
Veale, D. Advances in a cognitive behavioural model of body dysmorphic disorder. Body Image 1, 113–125 (2004).
Neziroglu, F., Khemlani-Patel, S. & Veale, D. Social learning theory and cognitive behavioral models of body dysmorphic disorder. Body Image 5, 28–38 (2008).
Veale, D. et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav. Res. Ther. 34, 717–729 (1996).
Fang, A. & Wilhelm, S. Clinical features, cognitive biases, and treatment of body dysmorphic disorder. Annu. Rev. Clin. Psychol. 11, 187–212 (2015).
Buhlmann, U., Etcoff, N. & Wilhelm, S. Emotion recognition bias for contempt and anger in body dysmorphic disorder. J. Psychiatr. Res. 40, 105–111 (2006).
Grennan, G., Zhao, Y. & Fang, A. Applying a drift diffusion model to test the effect of oxytocin on attentional biases in body dysmorphic disorder. J. Obsessive Compuls. Relat. Disord. 39, 100841 (2023).
Grace, S. A., Toh, W. L., Buchanan, B., Castle, D. J. & Rossell, S. L. Impaired recognition of negative facial emotions in body dysmorphic disorder. J. Int. Neuropsychol. Soc. 25, 884–889 (2019).
Feusner, J. D., Bystritsky, A., Hellemann, G. & Bookheimer, S. Impaired identity recognition of faces with emotional expressions in body dysmorphic disorder. Psychiatry Res. 179, 318–323 (2010).
Toh, W. L., Castle, D. J. & Rossell, S. L. Facial affect recognition in body dysmorphic disorder versus obsessive-compulsive disorder: an eye-tracking study. J. Anxiety Disord. 35, 49–59 (2015).
Greenberg, J. L., Reuman, L., Hartmann, A. S., Kasarskis, I. & Wilhelm, S. Visual hot spots: an eye tracking study of attention bias in body dysmorphic disorder. J. Psychiatr. Res. 57, 125–132 (2014).
Grocholewski, A., Kliem, S. & Heinrichs, N. Selective attention to imagined facial ugliness is specific to body dysmorphic disorder. Body Image 9, 261–269 (2012).
Kollei, I., Horndasch, S., Erim, Y. & Martin, A. Visual selective attention in body dysmorphic disorder, bulimia nervosa and healthy controls. J. Psychosom. Res. 92, 26–33 (2017).
Toh, W. L., Castle, D. J. & Rossell, S. L. How individuals with body dysmorphic disorder (BDD) process their own face: a quantitative and qualitative investigation based on an eye-tracking paradigm. Cogn. Neuropsychiatry 22, 213–232 (2017).
Dunai, J., Labuschagne, I., Castle, D. J., Kyrios, M. & Rossell, S. L. Executive function in body dysmorphic disorder. Psychol. Med. 40, 1541–1548 (2010).
Hanes, K. R. Neuropsychological performance in body dysmorphic disorder. J. Int. Neuropsychol. Soc. 4, 167–171 (1998).
Jefferies-Sewell, K., Chamberlain, S. R., Fineberg, N. A. & Laws, K. R. Cognitive dysfunction in body dysmorphic disorder: new implications for nosological systems and neurobiological models. CNS Spectr. 22, 51–60 (2017).
Greenberg, J. L. et al. Set shifting and visuospatial organization deficits in body dysmorphic disorder. Psychiatry Res. 260, 182–186 (2018).
Kerwin, L., Hovav, S., Hellemann, G. & Feusner, J. D. Impairment in local and global processing and set-shifting in body dysmorphic disorder. J. Psychiatr. Res. 57, 41–50 (2014).
Yousefi, A. et al. Examining memory performance in body dysmorphic disorder (BDD): a comparison study with obsessive compulsive disorder (OCD). Asian J. Psychiatr. 53, 102110 (2020).
Toh, W. L., Castle, D. J. & Rossell, S. L. Examining neurocognition in body dysmorphic disorder using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): a comparison with obsessive-compulsive disorder. Psychiatry Res. 228, 318–324 (2015).
Deckersbach, T. et al. Characteristics of memory dysfunction in body dysmorphic disorder. J. Int. Neuropsychol. Soc. 6, 673–681 (2000). This was the first study to suggest visuospatial organization deficits in BDD.
Toh, W. L., Castle, D. J. & Rossell, S. L. Face and object perception in body dysmorphic disorder versus obsessive-compulsive disorder: the mooney faces task. J. Int. Neuropsychol. Soc. 23, 471–480 (2017).
Jefferies, K., Laws, K. R. & Fineberg, N. A. Superior face recognition in body dysmorphic disorder. J. Obsessive Compuls. Relat. Disord. 1, 175–179 (2012).
Feusner, J. D. et al. Inverted face processing in body dysmorphic disorder. J. Psychiatr. Res. 44, 1088–1094 (2010).
Monzani, B., Krebs, G., Anson, M., Veale, D. & Mataix-Cols, D. Holistic versus detailed visual processing in body dysmorphic disorder: testing the inversion, composite and global precedence effects. Psychiatry Res. 210, 994–999 (2013).
Phillips, K. A. Body dysmorphic disorder: recognizing and treating imagined ugliness. World Psychiatry 3, 12–17 (2004).
Karsan, S., Diaz-Fong, J. P., Ly, R., Hellemann, G. & Feusner, J. D. Quantifying body size estimation accuracy and body dissatisfaction in body dysmorphic disorder using a digital avatar. Compr. Psychiatry 135, 152529 (2024).
Rauch, S. L. et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res. Neuroimaging 122, 13–19 (2003).
Atmaca, M. et al. Brain morphology of patients with body dysmorphic disorder. J. Affect. Disord. 123, 258–263 (2010).
Buchanan, B. et al. Regional brain volumes in body dysmorphic disorder compared to controls. Aust. N. Z. J. Psychiatry 48, 654–662 (2014).
Grace, S. A. et al. Reduced cortical thickness in body dysmorphic disorder. Psychiatry Res. Neuroimaging 259, 25–28 (2017).
Feusner, J. D. et al. Regional brain volumes and symptom severity in body dysmorphic disorder. Psychiatry Res. Neuroimaging 172, 161–167 (2009).
Madsen, S. K. et al. Cortical thickness and brain volumetric analysis in body dysmorphic disorder. Psychiatry Res. Neuroimaging 232, 115–122 (2015).
Feusner, J. D., Kurth, F., Luders, E., Ly, R. & Wong, W. Cytoarchitectonically defined volumes of early extrastriate visual cortex in unmedicated adults with body dysmorphic disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 8, 909–917 (2023). This is the largest BDD neuroimaging study, showing increased extrastriate visual cortex volumes.
Feusner, J. D. et al. White matter microstructure in body dysmorphic disorder and its clinical correlates. Psychiatry Res. Neuroimaging 211, 132–140 (2013).
Buchanan, B. G. et al. Brain connectivity in body dysmorphic disorder compared with controls: a diffusion tensor imaging study. Psychol. Med. 43, 2513–2521 (2013).
Arienzo, D. et al. Abnormal brain network organization in body dysmorphic disorder. Neuropsychopharmacology 38, 1130–1139 (2013).
Zhang, A. et al. Brain connectome modularity in weight-restored anorexia nervosa and body dysmorphic disorder. Psychol. Med. 46, 2785–2797 (2016).
Feusner, J. D., Townsend, J., Bystritsky, A. & Bookheimer, S. Visual information processing of faces in body dysmorphic disorder. Arch. Gen. Psychiatry 64, 1417 (2007).
Feusner, J. D. et al. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch. Gen. Psychiatry 67, 197 (2010).
Feusner, J. D., Hembacher, E., Moller, H. & Moody, T. D. Abnormalities of object visual processing in body dysmorphic disorder. Psychol. Med. 41, 2385–2397 (2011).
Li, W. et al. Anorexia nervosa and body dysmorphic disorder are associated with abnormalities in processing visual information. Psychol. Med. 45, 2111–2122 (2015).
Wong, W. et al. Neural and behavioral effects of modification of visual attention in body dysmorphic disorder. Transl. Psychiatry 12, 325 (2022).
Wong, W. et al. Can excitatory neuromodulation change distorted perception of one’s appearance? Brain Stimul. 14, 1197–1200 (2021).
Moody, T. D. et al. Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance. Brain Imaging Behav. 15, 1235–1252 (2021).
Beucke, J. C. et al. Degree connectivity in body dysmorphic disorder and relationships with obsessive and compulsive symptoms. Eur. Neuropsychopharmacol. 26, 1657–1666 (2016).
Wong, W. et al. Effects of visual attention modulation on dynamic functional connectivity during own-face viewing in body dysmorphic disorder. Neuropsychopharmacology 46, 2030–2038 (2021).
Anzai, A., Peng, X. & Van Essen, D. C. Neurons in monkey visual area V2 encode combinations of orientations. Nat. Neurosci. 10, 1313–1321 (2007).
Roe, A. W. et al. Toward a unified theory of visual area V4. Neuron 74, 12–29 (2012).
Milner, D. & Goodale, M. The Visual Brain in Action (Oxford University Press, 2006).
Rangaprakash, D. et al. Aberrant dynamic connectivity for fear processing in anorexia nervosa and body dysmorphic disorder. Front. Psychiatry 9, 273 (2018).
Weiner, K. S. & Zilles, K. The anatomical and functional specialization of the fusiform gyrus. Neuropsychologia 83, 48–62 (2016).
Borgers, T. et al. Brain functional correlates of emotional face processing in body dysmorphic disorder. J. Psychiatr. Res. 147, 103–110 (2022).
Grace, S. A., Labuschagne, I., Castle, D. J. & Rossell, S. L. Intranasal oxytocin alters amygdala-temporal resting-state functional connectivity in body dysmorphic disorder: a double-blind placebo-controlled randomized trial. Psychoneuroendocrinology 107, 179–186 (2019).
Pessoa, L. & Adolphs, R. Emotion processing and the amygdala: from a ‘low road’ to ‘many roads’ of evaluating biological significance. Nat. Rev. Neurosci. 11, 773–782 (2010).
Pizzagalli, D. A. et al. Affective judgments of faces modulate early activity (~160 ms) within the fusiform gyri. NeuroImage 16, 663–677 (2002).
Vuilleumier, P., Richardson, M. P., Armony, J. L., Driver, J. & Dolan, R. J. Distant influences of amygdala lesion on visual cortical activation during emotional face processing. Nat. Neurosci. 7, 1271–1278 (2004).
Kringelbach, M. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 72, 341–372 (2004).
Beucke, J. C. et al. Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder. JAMA Psychiatry 70, 619 (2013).
Ishizu, T. & Zeki, S. The brain’s specialized systems for aesthetic and perceptual judgment. Eur. J. Neurosci. 37, 1413–1420 (2013).
Iigaya, K. et al. Neural mechanisms underlying the hierarchical construction of perceived aesthetic value. Nat. Commun. 14, 127 (2023).
Hahn, A. C. & Perrett, D. I. Neural and behavioral responses to attractiveness in adult and infant faces. Neurosci. Biobehav. Rev. 46, 591–603 (2014).
O’Doherty, J., Kringelbach, M. L., Rolls, E. T., Hornak, J. & Andrews, C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat. Neurosci. 4, 95–102 (2001).
Marazziti, D. et al. Platelet [3H]paroxetine binding in patients with OCD-related disorders. Psychiatry Res. 89, 223–228 (1999).
Vulink, N. C., Planting, R. S., Figee, M., Booij, J. & Denys, D. Reduced striatal dopamine D 2/3 receptor availability in Body Dysmorphic Disorder. Eur. Neuropsychopharmacol. 26, 350–356 (2016).
Donaldson, Z. R. & Young, L. J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322, 900–904 (2008).
Leppanen, J., Ng, K. W., Tchanturia, K. & Treasure, J. Meta-analysis of the effects of intranasal oxytocin on interpretation and expression of emotions. Neurosci. Biobehav. Rev. 78, 125–144 (2017).
Fang, A. et al. Serum oxytocin levels are elevated in body dysmorphic disorder and related to severity of psychopathology. Psychoneuroendocrinology 113, 104541 (2020).
Phillips, K. A. et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress. Anxiety 27, 528–555 (2010).
Albertini, R. S. & Phillips, K. A. Thirty‐three cases of body dysmorphic disorder in children and adolescents. J. Am. Acad. Child. Adolesc. Psychiatry 38, 453–459 (1999).
Osman, S., Cooper, M., Hackmann, A. & Veale, D. Spontaneously occurring images and early memories in people with body dysmorphic disorder. Memory 12, 428–436 (2004).
Pope, C. G. et al. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image 2, 395–400 (2005).
Malcolm, A., Pikoos, T. D., Castle, D. J. & Rossell, S. L. An update on gender differences in major symptom phenomenology among adults with body dysmorphic disorder. Psychiatry Res. 295, 113619 (2021).
Boroughs, M. S., Krawczyk, R. & Thompson, J. K. Body dysmorphic disorder among diverse racial/ethnic and sexual orientation groups: prevalence estimates and associated factors. Sex Roles 63, 725–737 (2010).
Marques, L. et al. Body dysmorphic symptoms: phenomenology and ethnicity. Body Image 8, 163–167 (2011).
Krebs, G. et al. Practitioner review: assessment and treatment of body dysmorphic disorder in young people. J. Child Psychol. Psychiatry 65, 1119–1131 (2024).
Sarwer, D. B., Siminoff, L. A., Gardiner, H. M. & Spitzer, J. C. The psychosocial burden of visible disfigurement following traumatic injury. Front. Psychol. 13, 979574 (2022).
Clarke, A., Thompson, A. R., Jenkinson, E., Rumsey, N. & Newell, R. CBT for Appearance Anxiety: Psychosocial Interventions for Anxiety Due to Visible Difference (Wiley-Blackwell, 2013).
Phillips, K. A., Didie, E. R., Feusner, J. & Wilhelm, S. Body dysmorphic disorder: treating an underrecognized disorder. Am. J. Psychiatry 165, 1111–1118 (2008).
Veale, D. et al. Development of a cosmetic procedure screening questionnaire (COPS) for body dysmorphic disorder. J. Plast. Reconstr. Aesthet. Surg. 65, 530–532 (2012).
First, M., Williams, J., Karg, R. & Spitzer, R. Structured Clinical Interview for DSM-5, Research Version (SCID-5-RV) (American Psychiatric Publishing, 2015).
Phillips, K. A. In Assessment of Body Dysmorphic Disorder: Screening, Diagnosis, Severity, and Insight Ch. 17 (ed. Phillips, K. A.) 204–225 (Oxford University Press, 2017).
Tolin, D. F. et al. Psychometric properties of a structured diagnostic interview for DSM-5 anxiety, mood, and obsessive-compulsive and related disorders. Assessment 25, 3–13 (2018).
Phillips, K. A. et al. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol. Bull. 33, 17–22 (1997). This study outlines the development and psychometric properties of the most used rating scale for BDD.
Monzani, B. et al. Psychometric evaluation of the yale-brown obsessive-compulsive scale modified for body dysmorphic disorder for adolescents (BDD-YBOCS-A). Child Psychiatry Hum. Dev. 54, 1799–1806 (2023).
Fernández De La Cruz, L. et al. Empirically defining treatment response and remission in body dysmorphic disorder. Psychol. Med. 51, 83–89 (2021). This study provides empirically based conceptual and operational definitions of treatment response and full or partial remission in BDD with the aim to improving interpretation and comparison in clinical trials as well as communication among researchers, clinicians and patients.
Oosthuizen, P., Lambert, T. & Castle, D. J. Dysmorphic concern: prevalence and associations with clinical variables. Aust. N. Z. J. Psychiatry 32, 129–132 (1998).
Veale, D. et al. The appearance anxiety inventory: validation of a process measure in the treatment of body dysmorphic disorder. Behav. Cogn. Psychother. 42, 605–616 (2014).
Wilhelm, S., Greenberg, J. L., Rosenfield, E., Kasarskis, I. & Blashill, A. J. The body dysmorphic disorder symptom scale: development and preliminary validation of a self-report scale of symptom specific dysfunction. Body Image 17, 82–87 (2016).
Summers, B. J. et al. An evaluation of the body dysmorphic disorder symptom scale as a measure of treatment response and remission in psychotherapy and medication trials. Behav. Ther. 53, 521–534 (2022).
National Collaborating Centre for Mental Health, UK. Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder (British Psychological Society, 2006).
Castle, D. et al. Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology. Int. Clin. Psychopharmacol. 36, 61–75 (2021).
Bowyer, L., Krebs, G., Mataix-Cols, D., Veale, D. & Monzani, B. A critical review of cosmetic treatment outcomes in body dysmorphic disorder. Body Image 19, 1–8 (2016).
Veale, D. Outcome of cosmetic surgery and ‘DIY’ surgery in patients with body dysmorphic disorder. Psychiatr. Bull. 24, 218–221 (2000).
Zhao, F., Guo, Z., Bo, Y., Feng, L. & Zhao, J. Is cognitive behavioral therapy an efficacious treatment for psychological interventions in body dysmorphic disorders? A meta-analysis based on current evidence from randomized controlled trials. J. Affect. Disord. 352, 237–249 (2024).
Wilhelm, S., Phillips, K. A. & Steketee, G. Cognitive-Behavioral Therapy for Body Dysmorphic Disorder: A Treatment Manual (Guilford Press, 2013).
Veale, D. & Neziroglu, F. Body Dysmorphic Disorder: A Treatment Manual (Wiley, 2010).
Harrison, A. et al. Cognitive-behavioral therapy for body dysmorphic disorder: a systematic review and meta-analysis of randomized controlled trials. Clin. Psychol. Rev. 48, 43–51 (2016). This meta-analysis of seven RCTs, involving a total of 299 patients, demonstrated that CBT is effective relative to control conditions.
Mataix-Cols, D. et al. A pilot randomized controlled trial of cognitive-behavioral therapy for adolescents with body dysmorphic disorder. J. Am. Acad. Child Adolesc. Psychiatry 54, 895–904 (2015).
Rosen, J. C., Reiter, J. & Orosan, P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J. Consult. Clin. Psychol. 63, 263–269 (1995).
Veale, D., Miles, S. & Anson, M. Long-term outcome of cognitive behavior therapy for body dysmorphic disorder: a naturalistic case series of 1 to 4 years after a controlled trial. Behav. Ther. 46, 775–785 (2015).
Rautio, D. et al. Effectiveness of multimodal treatment for young people with body dysmorphic disorder in two specialist clinics. Behav. Ther. 53, 1037–1049 (2022).
Veale, D. et al. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial. Psychother. Psychosom. 83, 341–353 (2014).
Wilhelm, S. et al. Efficacy and posttreatment effects of therapist-delivered cognitive behavioral therapy vs supportive psychotherapy for adults with body dysmorphic disorder: a randomized clinical trial. JAMA Psychiatry 76, 363 (2019).
Hoeppner, S. S. et al. Time to response in therapy for body dysmorphic disorder: a comparison of cognitive behavioral therapy and supportive psychotherapy. Behav. Ther. 55, 68–79 (2024).
Greenberg, J. L., Mothi, S. S. & Wilhelm, S. Cognitive-behavioral therapy for adolescent body dysmorphic disorder: a pilot study. Behav. Ther. 47, 213–224 (2016).
Jassi, A. D., Baloch, A., Thomas-Smith, K. & Lewis, A. Family accommodation in pediatric body dysmorphic disorder: a qualitative study. Bull. Menn. Clin. 84, 319–336 (2020).
Marques, L., Weingarden, H. M., LeBlanc, N. J. & Wilhelm, S. Treatment utilization and barriers to treatment engagement among people with body dysmorphic symptoms. J. Psychosom. Res. 70, 286–293 (2011).
Wilhelm, S. et al. Development and pilot testing of a cognitive-behavioral therapy digital service for body dysmorphic disorder. Behav. Ther. 51, 15–26 (2020).
Wilhelm, S. et al. Efficacy of app-based cognitive behavioral therapy for body dysmorphic disorder with coach support: initial randomized controlled clinical trial. Psychother. Psychosom. 91, 277–285 (2022).
Flygare, O. et al. Cost-effectiveness of internet-delivered cognitive behaviour therapy for body dysmorphic disorder: results from a randomised controlled trial. Internet Interv. 31, 100604 (2023).
Lundström, L. et al. Effectiveness of Internet-based cognitive-behavioural therapy for obsessive-compulsive disorder (OCD-NET) and body dysmorphic disorder (BDD-NET) in the Swedish public health system using the RE-AIM implementation framework. Internet Interv. 31, 100608 (2023).
Rautio, D. et al. Therapist-guided, Internet-delivered cognitive behaviour therapy for adolescents with body dysmorphic disorder: a feasibility trial with long-term follow-up. Internet Interv. 34, 100688 (2023).
Phillips, K. A., Albertini, R. S. & Rasmussen, S. A. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch. Gen. Psychiatry 59, 381 (2002).
Hollander, E. et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch. Gen. Psychiatry 56, 1033 (1999).
Phillips, K. A. et al. Pharmacotherapy relapse prevention in body dysmorphic disorder: a double-blind, placebo-controlled trial. Am. J. Psychiatry 173, 887–895 (2016).
Phillips, K. A. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am. J. Psychiatry 162, 377–379 (2005).
Krebs, G., Rifkin-Zybutz, R., Clark, B. & Jassi, A. Access to evidence-based treatments for young people with body dysmorphic disorder. Arch. Dis. Child. 108, 684–685 (2023).
Hogg, E., Adamopoulos, P. & Krebs, G. Predictors and moderators of treatment response in cognitive behavioural therapy for body dysmorphic disorder: a systematic review. J. Obsessive Compuls. Relat. Disord. 38, 100822 (2023).
Koran, L. M. et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am. J. Psychiatry 164, 5–53 (2007).
Mchorney, C. A., Johne, W. & Anastasiae, R. The MOS 36-item short-form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31, 247–263 (1993).
Endicott, J., Nee, J., Harrison, W. & Blumenthal, R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol. Bull. 29, 321–326 (1993).
Sheehan, D. V., Harnett-Sheehan, K. & Raj, B. A. The measurement of disability. Int. Clin. Psychopharmacol. 11, 89–95 (1996).
Cash, T. F. & Fleming, E. C. The impact of body image experiences: development of the body image quality of life inventory. Int. J. Eat. Disord. 31, 455–460 (2002).
Phillips, K. A., Menard, W., Fay, C. & Pagano, M. E. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr. Psychiatry 46, 254–260 (2005).
IsHak, W. W. et al. Quality of life in body dysmorphic disorder. CNS Spectr. 17, 167–175 (2012).
Marques, L. et al. Correlates of quality of life and functional disability in individuals with body dysmorphic disorder. Psychosomatics 52, 245–254 (2011).
Torkian, A., Zanjani, Z., Pourkmali, Z. & Omidi, A. The effect of acceptance and commitment therapy on youth with body dysmorphic disorders symptoms: a randomized clinical trial. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-1416093/v1 (2022).
Linde, J., Luoma, J. B., Rück, C., Ramnerö, J. & Lundgren, T. Acceptance and compassion-based therapy targeting shame in body dysmorphic disorder: a multiple baseline study. Behav. Modif. 47, 693–718 (2023).
Mohajerin, B., Bakhtiyar, M., Olesnycky, O. S., Dolatshahi, B. & Motabi, F. Application of a transdiagnostic treatment for emotional disorders to body dysmorphic disorder: a randomized controlled trial. J. Affect. Disord. 245, 637–644 (2019).
Gu, Y.-Q. & Zhu, Y. A randomized controlled trial of mindfulness-based cognitive therapy for body dysmorphic disorder: impact on core symptoms, emotion dysregulation, and executive functioning. J. Behav. Ther. Exp. Psychiatry 81, 101869 (2023).
Schneier, F. R. et al. Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. J. Psychiatr. Res. 161, 364–370 (2023).
Holland, G. & Tiggemann, M. A systematic review of the impact of the use of social networking sites on body image and disordered eating outcomes. Body Image 17, 100–110 (2016).
De Vries, D. A., Peter, J., De Graaf, H. & Nikken, P. Adolescents’ social network site use, peer appearance-related feedback, and body dissatisfaction: testing a mediation model. J. Youth Adolescence 45, 211–224 (2016).
Zeeni, N., Doumit, R., Abi Kharma, J. & Sanchez‐Ruiz, M. Media, technology use, and attitudes: associations with physical and mental well‐being in youth with implications for evidence‐based practice. Worldviews Evid. Based Nurs. 15, 304–312 (2018).
Griffiths, S., Murray, S. B., Krug, I. & McLean, S. A. The contribution of social media to body dissatisfaction, eating disorder symptoms, and anabolic steroid use among sexual minority men. Cyberpsychol. Behav. Soc. Netw. 21, 149–156 (2018).
Alsaidan, M. S. et al. The prevalence and determinants of body dysmorphic disorder among young social media users: a cross-sectional study. Dermatol. Rep. 12, 8774 (2020).
Ateq, K., Alhajji, M. & Alhusseini, N. The association between use of social media and the development of body dysmorphic disorder and attitudes toward cosmetic surgeries: a national survey. Front. Public Health 12, 1324092 (2024).
Gupta, M., Jassi, A. & Krebs, G. The association between social media use and body dysmorphic symptoms in young people. Front. Psychol. 14, 1231801 (2023).
Thornhill, R. & Gangestad, S. W. Facial attractiveness. Trends Cogn. Sci. 3, 452–460 (1999).
Singh, D. Adaptive significance of female physical attractiveness: role of waist-to-hip ratio. J. Pers. Soc. Psychol. 65, 293–307 (1993).
Zahavi, A. & Kadman-Zahavi, A. The Handicap Principle: A Missing Piece of Darwin’s Puzzle (Oxford University Press, 1999).
Eibl-Eibesfeldt, I. Human Ethology (Aldine de Gruyter, 1989).
Buss, D. M. The evolution of human intrasexual competition: tactics of mate attraction. J. Pers. Soc. Psychol. 54, 616–628 (1988).
Feusner, J. D., Hembacher, E. & Phillips, K. A. The mouse who couldn’t stop washing: pathologic grooming in animals and humans. CNS Spectr. 14, 503–513 (2009).
Monzani, B. et al. A twin study of body dysmorphic concerns. Psychol. Med. 42, 1949–1955 (2012).
López‐Solà, C. et al. Prevalence and heritability of obsessive‐compulsive spectrum and anxiety disorder symptoms: a survey of the Australian Twin Registry. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165, 314–325 (2014).
Krebs, G. et al. The association between body dysmorphic symptoms and suicidality among adolescents and young adults: a genetically informative study. Psychol. Med. 52, 1268–1276 (2022).
Obsessive–Compulsive Disorder and Body Dysmorphic Disorder: Treatment (National Institute for Health and Care Excellence, 2005).
Haber, S. N. Corticostriatal circuitry. Dialogues Clin. Neurosci. 18, 7–21 (2016).
Phelps, E. A. & LeDoux, J. E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48, 175–187 (2005).
Hubel, D. H. & Wiesel, T. N. Receptive fields, binocular interaction and functional architecture in the cat’s visual cortex. J. Physiol. 160, 106–154 (1962).
Kurth, F., Jancke, L. & Luders, E. in Brain Morphometry (eds Spalletta, G. et al.) 121–129 (Humana Press, 2018).
Toh, W. L., Rossell, S. L. & Castle, D. J. Current visual scanpath research: a review of investigations into the psychotic, anxiety, and mood disorders. Compr. Psychiatry 52, 567–579 (2011).
Bullmore, E. & Sporns, O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 10, 186–198 (2009).
Navon, D. Forest before trees: the precedence of global features in visual perception. Cogn. Psychol. 9, 353–383 (1977).
Noton, D. & Stark, L. Eye movements and visual perception. Sci. Am. 224, 34–43 (1971).
Luck, S. J. & Vogel, E. K. Visual working memory capacity: from psychophysics and neurobiology to individual differences. Trends Cogn. Sci. 17, 391–400 (2013).
Filley, C. M. White matter: organization and functional relevance. Neuropsychol. Rev. 20, 158–173 (2010).
Acknowledgements
The authors thank L. Gunnarsson and S. Lindstedt for editorial assistance.
Author information
Authors and Affiliations
Contributions
Introduction (C.R.); Epidemiology (D.M.-C.); Mechanisms/pathophysiology (J.D.F.); Diagnosis, screening and prevention (L.F.d.l.C.); Management (G.K. and D.V.); Quality of life (R.G.S.); Outlook (C.R.); overview of the Primer (C.R.).
Corresponding author
Ethics declarations
Competing interests
L.F.d.l.C. receives royalties for contributing articles to UpToDate, Wolters Kluwer Health and for editorial work from Elsevier, outside the current work. D.M.-C. receives royalties for contributing articles to UpToDate, Wolters Kluwer Health and is part owner of Scandinavian E-Health, all outside the current work. J.D.F. has received consultation fees and stock options from NOCD, Inc. C.R. has received royalties from Studentlitteratur, Natur och Kultur and Albert Bonniers Förlag, all outside the current work. G.K. receives royalties from Elsevier for editorial work. All other authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Disease Primers thanks H. M. Weingarden; D. J. Castle; G. Grennan, who co-reviewed the article with A. Fang; and the other anonymous reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Acceptance and commitment therapy
-
A type of cognitive behavioural therapy that focuses on acceptance and mindfulness strategies along with commitment to action based on the patient’s own values and goals.
- Cytoarchitectonically defined
-
Regions defined using previously created brain maps based on microscopically-defined boundaries rather than macroscopic landmarks184.
- Dwell time
-
The number of visual fixations times the duration of each fixation185.
- Global efficiency
-
In the context of brain structural or functional networks, this applies to having many short and direct paths for information to flow quickly between different brain areas186.
- Global visual stimuli
-
Features that are processed as a whole, as opposed to being analysed by their individual components187.
- Local visual stimuli
-
Visual elements processed based on their finer details, individual components or smaller features rather than the overall structure or shape, or as a whole187.
- Scanpaths
-
Traces of the directions and extent of eye movements during viewing of complex visual stimuli over time, typically comprised of a series of fixations and saccades188.
- Visual working memory
-
A cognitive function that actively maintains visual information to serve the need of ongoing tasks189.
- White matter integrity
-
The degree that white matter nerve fibres (axons) are well-myelinated, have intact membranes and are well-organized, enabling efficient communication in the brain190.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rück, C., Mataix-Cols, D., Feusner, J.D. et al. Body dysmorphic disorder. Nat Rev Dis Primers 10, 92 (2024). https://doi.org/10.1038/s41572-024-00577-z
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41572-024-00577-z
This article is cited by
-
A personalized 3D printed cranial shield using mirror-image modeling: design and clinical assessment
3D Printing in Medicine (2025)


